Gardasil :: Merck’s Gardasil for Vaginal and Vulvar Cancers

Merck announced the Company has submitted a supplemental Biologics License Application (sBLA) for GARDASIL? [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] to the U.S. Food and Drug Administration (FDA) to update the labeling for GARDASIL, the cervical cancer vaccine.

E Coli :: HFX Corp. recalls beef due to E Coli contamination

HFX Corp. announced that the company has issued a voluntary recall for 259,230 pounds of beef products due to a possible contamination with E. coli 0157 bacteria. The United States Department of Agriculture announced the recall late Friday.

Bladder Cancer :: Scientists find one reason why bladder cancer hits more men

Scientists have discovered one of the reasons why bladder cancer is so much more prevalent in men than women: A molecular receptor or protein that is much more active in men than women plays a role in the development of the disease. The finding could open the door to new types of treatment with the disease.

Gardasil :: Merck submits new cross-protection data for Gardasil to FDA

Merck announced the Company has submitted a supplemental Biologics License Application (sBLA) for GARDASIL? [Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine] to the U.S. Food and Drug Administration (FDA) to update the labeling for GARDASIL, the cervical cancer vaccine.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack